Pique Therapeutics – Product Pipeline Review – 2012
Summary
Global Market Direct’s pharmaceuticals report, “Pique Therapeutics - Product Pipeline Review - 2012” provides data on the Pique Therapeutics’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Pique Therapeutics’s corporate website, SEC filings, investor presentations and featured press releases, both from Pique Therapeutics and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
Current R&D Portfolio of Pique Therapeutics; Pique Therapeutics - Key Therapeutics; Pique Therapeutics - Pipeline Overview and Promising Molecules; Pique Therapeutics - News; Pique Therapeutics - Latest Updates; Pique Therapeutics - Pipeline; Pique Therapeutics - Discontinued/Dormant Projects
Summary
Global Market Direct’s pharmaceuticals report, “Pique Therapeutics - Product Pipeline Review - 2012” provides data on the Pique Therapeutics’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Pique Therapeutics’s corporate website, SEC filings, investor presentations and featured press releases, both from Pique Therapeutics and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Pique Therapeutics - Brief Pique Therapeutics overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Pique Therapeutics human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Pique Therapeutics with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Pique Therapeutics’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
- Evaluate Pique Therapeutics’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Pique Therapeutics in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Pique Therapeutics’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Pique Therapeutics.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Pique Therapeutics and identify potential opportunities in those areas.
Current R&D Portfolio of Pique Therapeutics; Pique Therapeutics - Key Therapeutics; Pique Therapeutics - Pipeline Overview and Promising Molecules; Pique Therapeutics - News; Pique Therapeutics - Latest Updates; Pique Therapeutics - Pipeline; Pique Therapeutics - Discontinued/Dormant Projects
Pique Therapeutics Snapshot
Pique Therapeutics Overview
Key Information
Key Facts
Pique Therapeutics – Research and Development Overview
Key Therapeutic Areas
Pique Therapeutics – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pique Therapeutics – Pipeline Products Glance
Pique Therapeutics Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Pique Therapeutics – Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Pique Therapeutics – Drug Profiles
PT 107
Product Description
Mechanism of Action
R&D Progress
PT 123
Product Description
Mechanism of Action
R&D Progress
PT 128
Product Description
Mechanism of Action
R&D Progress
PT 207
Product Description
Mechanism of Action
R&D Progress
Pique Therapeutics – Pipeline Analysis
Pique Therapeutics – Pipeline Products by Therapeutic Class
Pique Therapeutics – Recent Pipeline Updates
Pique Therapeutics – Locations And Subsidiaries
Head Office
Financial Deals Landscape
Pique Therapeutics, Deals Summary
Pique Therapeutics, Pharmaceuticals & Healthcare, Deal Details
Venture Financing
Pique Therapeutics Secures $0.53 Million In Series A Round Of Financing
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
LIST OF TABLES
Pique Therapeutics, Key Information
Pique Therapeutics, Key Facts
Pique Therapeutics – Pipeline by Indication, 2012
Pique Therapeutics – Pipeline by Stage of Development, 2012
Pique Therapeutics – Monotherapy Products in Pipeline, 2012
Pique Therapeutics – Phase II, 2012
Pique Therapeutics – Pre-Clinical, 2012
Pique Therapeutics – Pipeline By Therapeutic Class, 2012
Pique Therapeutics – Recent Pipeline Updates, 2012
Pique Therapeutics, Deals Summary
Pique Therapeutics Secures $0.53 Million In Series A Round Of Financing
LIST OF FIGURES
Pique Therapeutics – Pipeline by Indication, 2012
Pique Therapeutics – Pipeline by Stage of Development, 2012
Pique Therapeutics – Monotherapy Products in Pipeline, 2012
Pique Therapeutics – Pipeline By Therapeutic Class, 2012
Pique Therapeutics Overview
Key Information
Key Facts
Pique Therapeutics – Research and Development Overview
Key Therapeutic Areas
Pique Therapeutics – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pique Therapeutics – Pipeline Products Glance
Pique Therapeutics Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Pique Therapeutics – Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Pique Therapeutics – Drug Profiles
PT 107
Product Description
Mechanism of Action
R&D Progress
PT 123
Product Description
Mechanism of Action
R&D Progress
PT 128
Product Description
Mechanism of Action
R&D Progress
PT 207
Product Description
Mechanism of Action
R&D Progress
Pique Therapeutics – Pipeline Analysis
Pique Therapeutics – Pipeline Products by Therapeutic Class
Pique Therapeutics – Recent Pipeline Updates
Pique Therapeutics – Locations And Subsidiaries
Head Office
Financial Deals Landscape
Pique Therapeutics, Deals Summary
Pique Therapeutics, Pharmaceuticals & Healthcare, Deal Details
Venture Financing
Pique Therapeutics Secures $0.53 Million In Series A Round Of Financing
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
LIST OF TABLES
Pique Therapeutics, Key Information
Pique Therapeutics, Key Facts
Pique Therapeutics – Pipeline by Indication, 2012
Pique Therapeutics – Pipeline by Stage of Development, 2012
Pique Therapeutics – Monotherapy Products in Pipeline, 2012
Pique Therapeutics – Phase II, 2012
Pique Therapeutics – Pre-Clinical, 2012
Pique Therapeutics – Pipeline By Therapeutic Class, 2012
Pique Therapeutics – Recent Pipeline Updates, 2012
Pique Therapeutics, Deals Summary
Pique Therapeutics Secures $0.53 Million In Series A Round Of Financing
LIST OF FIGURES
Pique Therapeutics – Pipeline by Indication, 2012
Pique Therapeutics – Pipeline by Stage of Development, 2012
Pique Therapeutics – Monotherapy Products in Pipeline, 2012
Pique Therapeutics – Pipeline By Therapeutic Class, 2012
